The Discounted Cash Flow (DCF) valuation of Guangxi Liuzhou Pharmaceutical Co Ltd (603368.SS) is 22.42 CNY. With the latest stock price at 17.13 CNY, the upside of Guangxi Liuzhou Pharmaceutical Co Ltd based on DCF is 30.9%.
Based on the latest price of 17.13 CNY and our DCF valuation, Guangxi Liuzhou Pharmaceutical Co Ltd (603368.SS) is a buy. buying 603368.SS stocks now will result in a potential gain of 30.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 7.6% | 6.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 13.28 - 45.16 | 22.42 |
| Upside | -22.5% - 163.6% | 30.9% |